OMB control number

Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act

OMB 0910-0800 · HHS/FDA.

OMB 0910-0800

This information collection supports implementation of Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act) - which governs pharmacy compounding and outsourcing facilities. The requirements include reporting, recordkeeping, and disclosures.

The latest form for Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act expires 2029-05-31 and is listed under ICR 202603-0910-014.

All Historical Document Collections

Historical document collections
ReferenceFilingReceivedConcludedAction
202603-0910-014 Extension without change of a currently approved collection 2026-03-27
202512-0910-009 Extension without change of a currently approved collection 2026-01-30 Improperly submitted and continue
202210-0910-015 Revision of a currently approved collection 2022-10-25 Approved without change
202005-0910-004 Revision of a currently approved collection 2020-05-14 Approved without change
201808-0910-004 Extension without change of a currently approved collection 2018-09-27 Approved without change
201507-0910-008 New collection (Request for a new OMB Control Number) 2015-08-04 Approved without change

OMB Details

503B Reporting: AERs

Federal Enterprise Architecture: Health - Consumer Health and Safety